Identification of novel PI3K inhibitors through a scaffold hopping strategy

被引：8
|
作者：
Martinez Gonzalez, Sonia [1 ]
Isabel Hernandez, Ana [1 ]
Maria Alvarez, Rosa [1 ]
Rodriguez, Antonio [1 ,2 ]
Ramos-Lima, Francisco [1 ]
Bischoff, James R. [1 ,3 ]
Isabel Albarran, Maria [1 ]
Cebria, Antonio [1 ]
Hernandez-Encinas, Elena [1 ]
Garcia-Arocha, Jennifer [1 ]
Cebrian, David [1 ,4 ]
Blanco-Aparicio, Carmen [1 ]
Pastor, Joaquin [1 ]
机构：
[1] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, C Melchor Fernandez Almagro 3, E-28029 Madrid, Spain
[2] Ctr Invest Lilly SA, Avda Ind,30, E-28108 Madrid, Spain
[3] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland
[4] GSK, Pharmacol Unit, Dis Developing World, C Severo Ochoa,2,Sci Business Technol Pk, E-28760 Madrid, Spain
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2017年 / 27卷 / 21期
关键词：
Scaffold hopping; ETP-46321; PI3K inhibitors; Back-up; CANCER; OPPORTUNITIES; CHALLENGES; ETP-46321; 3-KINASES; POTENT;
D O I：
10.1016/j.bmcl.2017.09.059
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A scaffold hopping strategy, including intellectual property availability assessment, was successfully applied for the discovery of novel PI3K inhibitors. Compounds were designed based on the chemical structure of the lead compound ETP-46321, a potent PI3K inhibitor, previously reported by our group. The new generated compounds showed good in vitro potency and selectivity, proved to inhibit potently the phosphorylation of AKT(Ser473) in cells and demonstrated to be orally bioavailable, thus becoming potential back-up candidates for ETP-46321. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4794 / 4799
页数：6
相关论文
共 50 条
  • [31] Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors
    Barlaam, Bernard
    Cosulich, Sabina
    Fitzek, Martina
    Germain, Herve
    Green, Stephen
    Hanson, Lyndsey L.
    Harris, Craig S.
    Hancox, Urs
    Hudson, Kevin
    Lambert-van der Brempt, Christine
    Lamorlette, Maryannick
    Magnien, Francoise
    Ouvry, Gilles
    Page, Ken
    Ruston, Linette
    Ward, Lara
    Delouvrie, Benedicte
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) : 3030 - 3035
  • [32] Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammation
    Ellard, Katie
    Sunose, Mihiro
    Bell, Kathryn
    Ramsden, Nigel
    Bergamini, Giovanna
    Neubauer, Gitte
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4546 - 4549
  • [33] Synthesis and Biological Activity of Novel PI3K/mTOR Inhibitors
    Wang Lei
    Zheng Guojun
    Ji Qi
    Chen Bo
    Gong Longlong
    Gao Congmin
    Du Zhenjian
    Zhang Xingmin
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2017, 38 (09): : 1590 - 1595
  • [34] PI3K Inhibitors of Novel Hydrazide Analogues Linked 2-Pyridinyl Quinazolone Scaffold as Anticancer Agents
    Zeid, Ibrahim F.
    Mohamed, Neama A.
    Khalifa, Nagy M.
    Kassem, Emad M.
    Nossier, Eman S.
    Salman, Ahmed A.
    Mahmoud, Khaled
    Al-Omar, Mohamed A.
    JOURNAL OF CHEMISTRY, 2019, 2019
  • [35] PI3K kinase and scaffold functions in heart
    Damilano, Federico
    Perino, Alessia
    Hirsch, Emilio
    ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE, 2010, 1188 : 39 - 45
  • [36] Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy
    Velcicky, Juraj
    Feifel, Roland
    Hawtin, Stuart
    Heng, Richard
    Huppertz, Christine
    Koch, Guido
    Kroemer, Markus
    Moebitz, Henrik
    Revesz, Laszlo
    Scheufler, Clemens
    Schlapbach, Achim
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1293 - 1297
  • [37] Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach
    Ganeshpurkar, Ankit
    Singh, Ravi
    Kumar, Devendra
    Gore, Pravin
    Shivhare, Shalini
    Sardana, Divya
    Rayala, Swetha
    Kumar, Ashok
    Singh, Sushil Kumar
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 203 : 195 - 211
  • [38] Development of anti-breast cancer PI3K inhibitors based on 7-azaindole derivatives through scaffold hopping: Design, synthesis and in vitro biological evaluation
    Yang, Chengbin
    Lu, Mingzhu
    Chen, Yi
    Xiang, Ruiqing
    Qiu, Tianze
    Jia, Yu
    Yang, Yongtai
    Liu, Xiaofeng
    Deng, Mingli
    Ling, Yun
    Zhou, Yaming
    BIOORGANIC CHEMISTRY, 2021, 117
  • [39] INITIAL EVALUATION OF NOVEL DUAL PIM/PI3K AND TRIPLE PIM/PI3K/MTOR INHIBITORS IN MULTIPLE MYELOMA
    Reidy, M.
    vanDijk, M.
    Keane, N.
    O'Neill, M.
    O'Dwyer, M. E.
    HAEMATOLOGICA, 2015, 100 : 496 - 497
  • [40] Initial Evaluation of Novel Dual PIM/PI3K and Triple PIM/PI3K/mTOR Inhibitors in Multiple Myeloma
    Reidy, Mairead
    vanDijk, Marianne
    Keane, Niamh
    O'Neill, Michael
    O'Dwyer, Michael E.
    BLOOD, 2014, 124 (21)
12345